LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP6 | 3 | C19 | 72 | hr | 2543 | 239 | 5578 | 0.0428 | -0.7592 |
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP6 | 1 | C19 | 72 | hr | 2543 | 298 | 5578 | 0.0534 | -0.7398 |
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP6 | 2 | C19 | 72 | hr | 2543 | 348 | 5578 | 0.0624 | -0.7233 |
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP5 | 1 | C19 | 72 | hr | 2543 | 423 | 5578 | 0.0758 | -0.6986 |
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP5 | 2 | C19 | 72 | hr | 2543 | 479 | 5578 | 0.0859 | -0.6802 |
| SK-BR-3 | LDN-193189 | 10.0 | uM | LJP5 | 2 | G01 | 72 | hr | 2543 | 535 | 5578 | 0.0959 | -0.6617 |
| SK-BR-3 | Geldanamycin | 10.0 | uM | LJP5 | 2 | O01 | 72 | hr | 2543 | 578 | 5578 | 0.1036 | -0.6476 |
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP5 | 3 | C19 | 72 | hr | 2543 | 582 | 5578 | 0.1043 | -0.6462 |
| SK-BR-3 | AT-7519 | 10.0 | uM | LJP6 | 1 | K01 | 72 | hr | 2543 | 602 | 5578 | 0.1079 | -0.6397 |
| SK-BR-3 | Omipalisib | 10.0 | uM | LJP6 | 1 | N01 | 72 | hr | 2543 | 635 | 5578 | 0.1138 | -0.6288 |
| SK-BR-3 | GSK1059615 | 10.0 | uM | LJP5 | 2 | E01 | 72 | hr | 2543 | 650 | 5578 | 0.1165 | -0.6238 |
| SK-BR-3 | AZD 5438 | 10.0 | uM | LJP6 | 2 | J01 | 72 | hr | 2543 | 657 | 5578 | 0.1178 | -0.6215 |
| SK-BR-3 | CGP60474 | 10.0 | uM | LJP6 | 1 | G01 | 72 | hr | 2543 | 670 | 5578 | 0.1201 | -0.6172 |
| SK-BR-3 | AZD 5438 | 10.0 | uM | LJP6 | 1 | J01 | 72 | hr | 2543 | 694 | 5578 | 0.1244 | -0.6093 |
| SK-BR-3 | CGP60474 | 10.0 | uM | LJP6 | 3 | G01 | 72 | hr | 2543 | 707 | 5578 | 0.1267 | -0.6051 |
| SK-BR-3 | Alvocidib | 0.37 | uM | LJP6 | 1 | A16 | 72 | hr | 2543 | 714 | 5578 | 0.1280 | -0.6028 |
| SK-BR-3 | AT-7519 | 10.0 | uM | LJP6 | 3 | K01 | 72 | hr | 2543 | 722 | 5578 | 0.1294 | -0.6001 |
| SK-BR-3 | Omipalisib | 10.0 | uM | LJP6 | 2 | N01 | 72 | hr | 2543 | 734 | 5578 | 0.1316 | -0.5962 |
| SK-BR-3 | Omipalisib | 10.0 | uM | LJP6 | 3 | N01 | 72 | hr | 2543 | 739 | 5578 | 0.1325 | -0.5945 |
| SK-BR-3 | AT-7519 | 10.0 | uM | LJP6 | 2 | K01 | 72 | hr | 2543 | 769 | 5578 | 0.1379 | -0.5846 |
| SK-BR-3 | Alvocidib | 3.33 | uM | LJP6 | 1 | A14 | 72 | hr | 2543 | 773 | 5578 | 0.1386 | -0.5833 |
| SK-BR-3 | Alvocidib | 1.11 | uM | LJP6 | 1 | A15 | 72 | hr | 2543 | 802 | 5578 | 0.1438 | -0.5738 |
| SK-BR-3 | Alvocidib | 10.0 | uM | LJP6 | 3 | A13 | 72 | hr | 2543 | 819 | 5578 | 0.1468 | -0.5682 |
| SK-BR-3 | CGP60474 | 10.0 | uM | LJP6 | 2 | G01 | 72 | hr | 2543 | 840 | 5578 | 0.1506 | -0.5612 |
| SK-BR-3 | AZD 5438 | 10.0 | uM | LJP6 | 3 | J01 | 72 | hr | 2543 | 850 | 5578 | 0.1524 | -0.5579 |